Cargando…
Contrast Sensitivity Changes in Center Involving Diabetic Macular Edema Treated with Aflibercept
PURPOSE: To characterize the changes in contrast sensitivity (CS) and retinal anatomy in patients with center involving diabetic macular edema (CDME) measured from baseline to post-loading doses of aflibercept. PATIENTS AND METHODS: This single center, prospective, open-label, non-controlled evaluat...
Autores principales: | Nixon, Donald R, Flinn, Nicholas, Enderlein, Claudia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593693/ https://www.ncbi.nlm.nih.gov/pubmed/34795475 http://dx.doi.org/10.2147/OPTH.S338478 |
Ejemplares similares
-
Evaluation of contrast sensitivity and other visual function outcomes in diabetic macular edema patients following treatment switch to aflibercept from ranibizumab
por: Nixon, Donald R, et al.
Publicado: (2018) -
Evaluation of contrast sensitivity and other visual function outcomes in neovascular age-related macular degeneration patients after treatment switch to aflibercept from ranibizumab
por: Nixon, Donald R, et al.
Publicado: (2017) -
Comparison of the Effect of Ranibizumab and Aflibercept on Changes in Macular Choroidal Thickness in Patients Treated for Diabetic Macular Edema
por: Sarda, Valérie, et al.
Publicado: (2020) -
The role of aflibercept in the management of diabetic macular edema
por: Chang, Andrew A, et al.
Publicado: (2015) -
The clinical utility of aflibercept for diabetic macular edema
por: Stewart, Michael W
Publicado: (2015)